Smith Group Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-720
| Closed | -$36K | – | 319 |
|
|
2020
Q2 | $36K | Sell |
720
-20
| -3% | -$1K | ﹤0.01% | 216 |
|
|
2020
Q1 | $38K | Hold |
740
| – | – | ﹤0.01% | 255 |
|
|
2019
Q4 | $46K | Hold |
740
| – | – | ﹤0.01% | 285 |
|
|
2019
Q3 | $44K | Buy |
740
+220
| +42% | +$13.1K | ﹤0.01% | 285 |
|
|
2019
Q2 | $44K | Hold |
520
| – | – | ﹤0.01% | 281 |
|
|
2019
Q1 | $50K | Sell |
520
-1,300
| -71% | -$125K | ﹤0.01% | 299 |
|
|
2018
Q4 | $129K | Sell |
1,820
-200
| -10% | -$14.2K | ﹤0.01% | 271 |
|
|
2018
Q3 | $173K | Buy |
+2,020
| New | +$173K | ﹤0.01% | 254 |
|
|
2015
Q1 | – | Sell |
-677
| Closed | -$34K | – | 423 |
|
|
2014
Q4 | $34K | Hold |
677
| – | – | ﹤0.01% | 329 |
|
|
2014
Q3 | $27K | Hold |
677
| – | – | ﹤0.01% | 291 |
|
|
2014
Q2 | $29K | Sell |
677
-1,230
| -64% | -$52.7K | ﹤0.01% | 297 |
|
|
2014
Q1 | $76K | Sell |
1,907
-550
| -22% | -$21.9K | ﹤0.01% | 240 |
|
|
2013
Q4 | $67K | Hold |
2,457
| – | – | ﹤0.01% | 227 |
|
|
2013
Q3 | $56K | Buy |
+2,457
| New | +$56K | ﹤0.01% | 236 |
|